U.S. Supreme Court to Decide Pivotal Roundup Case
Case Works today announced the appointment of Kim Anderson as CEO and Board Member. Susan Barfield, Founder, will remain Board Chair.
Case Works, LLC Appoints New Executive Leadership to Accelerate Growth and Strategic Expansion
Case Works today announced the appointment of Kim Anderson as CEO and Board Member. Susan Barfield, Founder, will remain Board Chair.
NEC Venue and Judge Update April 2022
Contact Case Works To Discuss NEC Case Development Services Today Contact Case Works Today To Set Up a Consultation
Best Litigation Funding Companies
Best Litigation Funding Companies When you need financing for plaintiff litigation, you want to make sure you choose the best financial product and lender that …
What Are Plaintiff Fact Sheets?
When multiple people experience similar injuries due to a negligent or wrongful action by the same defendant or defendants, victims in various locations can file …
Talcum Powder Summary Update February 2022
The U.S. Bankruptcy Court of New Jersey extended an automatic stay that prevents talcum claimants from collecting against non-debtors at the request of LTL Management.
CPAP MDL Plaintiffs’ Counsel Leadership Announced
Users of machines for sleep apnea and ventilators that Philips makes have filed a flood of lawsuits alleging health injuries from degraded polyester-based polyurethane (PE-PUR) in the devices. The …
How to Build a Mass Tort Practice
How to Build a Mass Tort Practice Many attorneys experienced in personal injury wonder about expanding their practice from personal injury to mass tort litigation. …
Litigation Support Services
Litigation support services encompass a wide range of services that support businesses, professionals, and lawyers in preparation for trial or settlement. From document review, to …
What is Litigation Funding?
Third-party litigation funding occurs when a litigant receives funding in exchange for an interest in any potential recovery, according to the ABA. The litigant may receive …
Training Process for Intake Staff: The First and Most Crucial Process of Client Contact
Law firm intake staff are the first people to have contact with a client or potential client. A prospective client’s experience with intake staff sets …
What is a demand letter?
A well-crafted demand letter is one of the most effective tools for protecting, preserving, and enforcing clients’ rights. But you don’t have to be a …
Mass Tort Lead Generation
Mass Tort Lead Generation Lead generation and mass tort cases are the lifeblood of law firms that pursue defective drug and medical device claims for …
Mass Tort Talks featuring Susan Barfield
https://youtu.be/FmwfBTU4jXw Presented by The Mass Tort Institute Hi, my name is Susan and I am the founder and CEO of Case Works. My goal today …
COVID-19’s Impact on the Mass Tort Landscape
COVID-19’s Impact on the Mass Tort Landscape The mass tort landscape is reaching a new peak while COVID-19 outbreaks and the Delta variant continue to …
The Biggest Challenges for Mass Tort Firms
Mass tort litigation firms stand to recover large settlement amounts for their clients in mass tort litigation proceedings.
Advantages of Outsourcing Client Case Management
Whether you need to outsource core functions, simple business functions, or just looking for cost savings, outsourcing business processes and operations can benefit all types of law firms.
Zantac Litigation Update: Latest Developments
The mass action litigation against the makers of the popular antacid medication Zantac is still in the early stages. On April 1, 2020, the U.S. Food and Drug Administration (FDA) issued an immediate market withdrawal request of all ranitidine-based medications including Zantac.
PFAS Victims Reach Two Major Settlement Deals
DuPont and several related companies have committed $4 billion to cover liabilities stemming from their past use of toxic “forever chemicals” such as PFAS and PFOA. The group of companies also agreed to pay $83 million to settle multidistrict litigation in Ohio to compensate victims harmed by the chemicals.
$8.3 Billion Purdue Opioid Settlement Update
In mid-November 2020, the U.S. Bankruptcy Court for the Southern District of New York approved a federal settlement agreement valued at $8.3 billion between Purdue Pharma and the Department of Justice (DOJ). As part of the deal, Purdue will plead guilty to 3 felony criminal counts of defrauding the United States.